michael lubbert (22 résultats)

Hardcover. Etat : Sehr gut. 1. Auflage. 156 pages with many coloured illustrations.

Hardcover. Etat : As New. Leichte Kratzer / Abnutzungen / Druckstellen. Myelodysplastische Syndrome (MDS) und akute myeloische Leukämien (AML) sind keine völlig unabhängigen Krankheitsentitäten, sondern stellen in vielerlei Hinsicht ein biologisches Kontinuum dar.Dieses Buch erläutert in der nun vorliegenden 2. Auflage die pathophysiologischen Grundlagen und stellt die aktuellen Klassifikationen von MDS und AML sowie die prognostischen Systeme dar. Die verschiedenen Behandlungsoptionen wie z.B. Kinase-Inhibition, Angiogenese-Hemmung, Induktionschemotherapie und Stammzelltransplantation sowie die Auswahlkriterien der jeweiligen Therapiemodalitäten werden ausführlich diskutiert.Dieses Lehrbuch vermittelt die Erfahrungen namhafter Experten und ermöglicht einen fundierten Überblick über die aktuellen diagnostischen und therapeutischen Möglichkeiten bei MDS und AML.

Etat : Sehr gut. - Mit zahlreichen, meist farbigen Abb. ; Erschien als Katalog der Ausstellung im Möllner Museum Historisches Rathaus vom 30. Oktober 1994 - 10. Dezember 1994. // Sauberes, frisches Exemplar. Sprache: Deutsch Gewicht in Gramm: 400 4°, 48 S., weißer, farb. illustr. Org.-Brosch.

Softcover. Etat : Sehr gut. 48 S.mit Abbildungen; Original-Karton; Gr.8°. Sehr gutes Exemplar.

Etat : New. In.

Etat : New. In.

Hardcover. Etat : Brand New. 1st edition. 325 pages. 9.25x6.25x0.75 inches. In Stock.

Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.

Taschenbuch. Etat : Neu. Epigenetic Therapy of Cancer | Preclinical Models and Treatment Approaches | Michael Lübbert (u. a.) | Taschenbuch | x | Englisch | 2016 | Springer | EAN 9783662519288 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

Hardcover. Etat : Like New. Like New. book.

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.

Etat : New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 6-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Paperback. Etat : Like New. Like New. book.

Etat : new. Questo è un articolo print on demand.

Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail. 336 pp. Englisch.

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Devotes detailed attention to the translation of basic research and drug development to clinical applications in the treatment of solid tumors as well as hematologic malignancies and hemoglobinopathyPresents the latest evidence derived from precli.

Etat : new. Questo è un articolo print on demand.

Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 336 pp. Englisch.

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail. 336 pp. Englisch.

Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Devotes detailed attention to the translation of basic research and drug development to clinical applications in the treatment of solid tumors as well as hematologic malignancies and hemoglobinopathyPresents the latest evidence derived from precli.

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The growing knowledge about disturbances of epigenetic gene regulation in hematopoietic stem cell disorders is now being translated into treatment approaches that target the epigenetic defects pharmacologically. This book first presents the latest evidence regarding the epigenetic regulation of hematopoietic stem cell differentiation and hemoglobin production. The significance of DNA methylation abnormalities in hematopoietic disorders and of epigenetic disturbances in lung cancer and other solid tumors is then discussed. A major part of the book, however, relates specifically to the translation of basic research and drug development to clinical applications, and in this context both present and future clinical strategies are considered. Individual chapters are devoted to the use of DNA hypomethylating agents and chromatin-modifying agents, and the treatment of hematologic malignancies and solid tumors by means of epigenetic agents is discussed in detail.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 336 pp. Englisch.

Etat : New. PRINT ON DEMAND pp. 336.